Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06282523 · ClinicalTrials.gov registry record · NA
Healthy Minds Comparison Study
A NA study of Depression and Anxiety, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 532
- Enrollment target
- 1
- Study location
NCT06282523: Completed NA study of Depression and Anxiety, sponsored by University of Wisconsin, Madison.
NCT06282523 is a NA study of Depression and Anxiety that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 532 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06282523, a NA study of Depression and Anxiety, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 532 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to understand the difference between two versions of the Healthy Minds application, a digital well-being program. The main question it aims to answer is the differences between versions of the Healthy Minds application and their effects on well-being. Participants will complete an online four-week well-being program and complete surveys sent to their email. Participants can expect to participate in the study for four months.
Primary Outcome
Psychological distress will be computed as a composite of the PROMIS Depression and PROMIS Anxiety measures. We will use the computer adaptive version of both measures which have a mean of 50 and a standard deviation of 10. A composite will be computed by average across T-scores. T-scores range from 10 to 90 with higher scores indicating higher depression or anxiety.
Conditions Studied
Interventions
- BEHAVIORAL HMP app
- BEHAVIORAL HMRP web app
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 532 participants |
| Start Date | 2024-06-19 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT06282523 record still lists
NCT06282523 is an interventional study that assigns participants to a tested intervention. The registered 532 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 679 other Depression trials with a reported enrollment target (32% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which HMP app is the first listed.
NCT06282523 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06282523 about?
NCT06282523 is a clinical study titled "Healthy Minds Comparison Study". The goal of this clinical trial is to understand the difference between two versions of the Healthy Minds application, a digital well-being program. The main question it aims to answer is the differences between versions of the Healthy Minds application and their effects on well-being. Participants...
What is the current status of trial NCT06282523?
This trial is currently completed. It is a NA study. The enrollment target is 532 participants. The study started on 2024-06-19. Estimated completion is 2024-12-31.
What conditions does trial NCT06282523 study?
This clinical trial studies the following conditions: Depression, Anxiety, Depression, Anxiety.
What interventions are being tested in trial NCT06282523?
The interventions under investigation include: HMP app (BEHAVIORAL), HMRP web app (BEHAVIORAL).
Who is sponsoring clinical trial NCT06282523?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06282523 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06282523's enrollment target sits among peer trials
532 73rd of 679 higher than 607 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05793151 · 532 participants · NA
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- NCT06378866 · 532 participants · Phase 2
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- NCT07219173 · 531 participants · Phase 2
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy